Stryker (NYSE: SYK) reported Q1 EPS of $1.88, $0.04 better than the analyst estimate of $1.84. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.52 billion.

GUIDANCE:

Stryker sees Q2 2019 EPS of $1.90-$1.95, versus the consensus of $1.96.

Stryker sees FY2019 EPS of $8.05-$8.20, versus the consensus of $8.13.

• Based on our first quarter performance we now expect 2019 organic net sales growth to be in the range of 6.8% to 7.5% and expect adjusted net earnings per diluted share(2) to be in the range of $8.05 to $8.20. For the second quarter we expect adjusted net earnings per diluted share(2) to be in the range of $1.90 to $1.95. If foreign currency exchange rates hold near current levels, we expect net sales in the second quarter will be negatively impacted by approximately 1.5% and full year will be negatively impacted by approximately 1.0%, and net earnings per diluted share will be negatively impacted by $0.01 to $0.03 in the second quarter and negatively impacted by $0.05 to $0.10 in the full year.

For earnings history and earnings-related data on Stryker (SYK) click here.